MoviPrep

Salix Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 31, 2025
Approval ID: 8ff46193-2a3b-4de0-9572-775dda8cd8b2
Products: 1 registered
Version: 43

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MOVIPREP safely and effectively. See full prescribing information for MOVIPREP. MOVIPREP® (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution)Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.